D-Pharm Ltd. (TASE: DPRM) announced today, publication in PLOS ONE, of promising results from a study of its drug candidate DP-b99. The findings suggest that DP-b99 may prevent lasting alterations in ...
On April 29, 2022, the Centers for Medicare and Medicaid Services (CMS) issued its final rule, Medicare Advantage and Part D Final Rule for Contract Year 2024, which requires Part D plans to include ...
Under preferred pharmacy networks, unsubsidized Part D beneficiaries faced substantial incentives and moderately switched toward preferred pharmacies, whereas subsidized beneficiaries were insulated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback